Effect of Anti-diabetic Drugs on Glycemic Variability

NCT02925559 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Dapagliflozin
DRUG: Gliclazide MR

Sponsor

Centro de Diabetes Curitiba Ltda

Collaborators

[object Object]